THEM6
gene geneOn this page
Also known as DSCD75
Summary
THEM6 (thioesterase superfamily member 6, HGNC:29656) is a protein-coding gene on chromosome 8q24.3, encoding Protein THEM6 (Q8WUY1).
Predicted to be located in extracellular region.
Source: NCBI Gene 51337 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- Druggable target: yes
- MANE Select transcript:
NM_016647
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29656 |
| Approved symbol | THEM6 |
| Name | thioesterase superfamily member 6 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DSCD75 |
| Ensembl gene | ENSG00000130193 |
| Ensembl biotype | protein_coding |
| Entrez | 51337 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000336138, ENST00000518798, ENST00000520217, ENST00000866704, ENST00000866705, ENST00000866706
RefSeq mRNA: 2 — MANE Select: NM_016647
NM_001363000, NM_016647
CCDS: CCDS6386
Canonical transcript exons
ENST00000336138 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001355879 | 142735326 | 142736927 |
| ENSE00001355886 | 142727223 | 142727859 |
Expression profiles
Bgee: expression breadth ubiquitous, 188 present calls, max score 90.66.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 21.6223 / max 243.1974, expressed in 1738 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91364 | 15.4222 | 1670 |
| 91363 | 6.2001 | 1457 |
Top tissues by expression
271 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 90.66 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.40 | gold quality |
| apex of heart | UBERON:0002098 | 87.37 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.14 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.95 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.88 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.71 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.36 | gold quality |
| body of pancreas | UBERON:0001150 | 85.32 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 85.13 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.10 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.90 | gold quality |
| esophagus mucosa | UBERON:0002469 | 84.48 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.28 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.70 | gold quality |
| adrenal cortex | UBERON:0001235 | 83.64 | gold quality |
| body of stomach | UBERON:0001161 | 83.35 | gold quality |
| right uterine tube | UBERON:0001302 | 83.20 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 83.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 83.04 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.98 | gold quality |
| cingulate cortex | UBERON:0003027 | 82.90 | gold quality |
| skin of leg | UBERON:0001511 | 82.80 | gold quality |
| minor salivary gland | UBERON:0001830 | 82.56 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.50 | gold quality |
| transverse colon | UBERON:0001157 | 82.37 | gold quality |
| liver | UBERON:0002107 | 82.33 | gold quality |
| cardiac ventricle | UBERON:0002082 | 82.27 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 82.16 | gold quality |
| adrenal gland | UBERON:0002369 | 82.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting THEM6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4650-5P | 99.98 | 64.69 | 999 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-106A-3P | 99.53 | 67.58 | 995 |
| HSA-MIR-3147 | 99.52 | 66.34 | 388 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-1301-3P | 98.64 | 68.27 | 1071 |
| HSA-MIR-5047 | 98.64 | 68.62 | 1035 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
| HSA-MIR-4632-5P | 97.82 | 65.38 | 1470 |
| HSA-MIR-4660 | 97.79 | 67.44 | 1328 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-3616-3P | 96.96 | 65.45 | 983 |
Literature-anchored findings (GeneRIF, showing 1)
- THEM6 is a prognostic biomarker for breast cancer and is associated with immune infiltration. (PMID:38081884)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | them6 | ENSDARG00000100260 |
| danio_rerio | THEM6 | ENSDARG00000103914 |
| mus_musculus | Them6 | ENSMUSG00000056665 |
| rattus_norvegicus | Them6 | ENSRNOG00000005929 |
| drosophila_melanogaster | CG4666 | FBGN0029838 |
| drosophila_melanogaster | CG4660 | FBGN0029839 |
Protein
Protein identifiers
Protein THEM6 — Q8WUY1 (reviewed: Q8WUY1)
Alternative names: Mesenchymal stem cell protein DSCD75, Thioesterase superfamily member 6
All UniProt accessions (3): Q8WUY1, B4DWJ7, H0YAR9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the THEM6 family.
RefSeq proteins (2): NP_001349929, NP_057731* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029069 | HotDog_dom_sf | Homologous_superfamily |
| IPR051490 | THEM6_lcsJ_thioesterase | Family |
Pfam: PF13279
UniProt features (5 total): signal peptide 1, chain 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WUY1-F1 | 94.92 | 0.96 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 199
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, GRADE_COLON_AND_RECTAL_CANCER_UP, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GEORGES_TARGETS_OF_MIR192_AND_MIR215, chr8q24, ERBB2_UP.V1_UP, MEK_UP.V1_UP, PTEN_DN.V2_DN, RPS14_DN.V1_DN, STK33_NOMO_DN, FEV_TARGET_GENES, FOXD2_TARGET_GENES, PCGF1_TARGET_GENES, PHF21A_TARGET_GENES, SKIL_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
388 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| THEM6 | FLYWCH2 | Q96CP2 | 471 |
| THEM6 | TMEM200A | Q86VY9 | 459 |
| THEM6 | SYNGR4 | O95473 | 454 |
| THEM6 | PROSER2 | Q86WR7 | 436 |
| THEM6 | TMEM220 | Q6QAJ8 | 430 |
| THEM6 | JRK | O75564 | 425 |
| THEM6 | SLC4A7 | Q9Y6M7 | 403 |
| THEM6 | LYNX1 | P0DP58 | 389 |
| THEM6 | ANKRD29 | Q8N6D5 | 358 |
| THEM6 | NCKAP5L | Q9HCH0 | 348 |
| THEM6 | PLEKHG1 | Q9ULL1 | 336 |
| THEM6 | UBXN2B | Q14CS0 | 323 |
| THEM6 | LETM1 | O95202 | 320 |
| THEM6 | SEPTIN5 | Q99719 | 315 |
| THEM6 | MID1IP1 | Q9NPA3 | 314 |
IntAct
123 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IFT70B | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| P2RX4 | FAM20B | psi-mi:“MI:0914”(association) | 0.640 |
| TEX28 | TMCC2 | psi-mi:“MI:0914”(association) | 0.640 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| GDPD5 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| XPO1 | psi-mi:“MI:0914”(association) | 0.530 | |
| SRPRB | CTDNEP1 | psi-mi:“MI:0914”(association) | 0.530 |
| TBC1D15 | UBXN8 | psi-mi:“MI:0914”(association) | 0.530 |
| APLNR | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| EVA1C | STK25 | psi-mi:“MI:0914”(association) | 0.530 |
| SIDT2 | AP3D1 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM63A | AP3D1 | psi-mi:“MI:0914”(association) | 0.530 |
| CHRNA4 | FZD6 | psi-mi:“MI:0914”(association) | 0.530 |
| LDLRAD1 | ADAM10 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC30A2 | ESYT2 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC6A8 | ILVBL | psi-mi:“MI:0914”(association) | 0.530 |
| UNC93B1 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| ERBB2 | NDUFA4 | psi-mi:“MI:0914”(association) | 0.530 |
| ESR1 | psi-mi:“MI:0914”(association) | 0.460 | |
| FLT4 | ILVBL | psi-mi:“MI:0914”(association) | 0.420 |
| Them6 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| CFTR | SNHG32 | psi-mi:“MI:0914”(association) | 0.350 |
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (180): THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS)
ESM2 similar proteins: A1A4L8, A1A4Q9, A1L134, A2BDX3, A5YM72, A6H707, B0BLZ5, B0JZP3, G3MZR2, O43292, O60831, O89109, P70295, Q11130, Q2TBP5, Q2V8X7, Q32NY4, Q3UPE3, Q4R4E4, Q4R4I9, Q5XIE1, Q5ZIW1, Q66HR0, Q6IQX7, Q6NRK8, Q6P2H8, Q7L1V2, Q80ZW2, Q86VU5, Q8IZ52, Q8N3Y3, Q8NE01, Q8NF37, Q8NI29, Q8TAC2, Q8TCD5, Q8TD43, Q8WUY1, Q92839, Q96DE0
Diamond homologs: A6H707, B0BLZ5, B0JZP3, Q5XIE1, Q6NRK8, Q80ZW2, Q8WUY1, Q9W440
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 167 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Synthesis of PC | 5 | 18.4× | 9e-04 |
| R-HSA-425393 | 10 | 11.7× | 3e-06 |
| SLC-mediated transmembrane transport | 13 | 6.9× | 8e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| phosphatidylcholine biosynthetic process | 5 | 28.1× | 4e-04 |
| cell volume homeostasis | 5 | 21.0× | 9e-04 |
| amino acid transport | 6 | 13.1× | 1e-03 |
| transmembrane transport | 11 | 13.0× | 8e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:142727858:GG:G | donor_gain | 1.0000 |
| 8:142727859:GG:G | donor_gain | 1.0000 |
| 8:142735314:T:TA | acceptor_gain | 1.0000 |
| 8:142735323:CA:C | acceptor_loss | 1.0000 |
| 8:142735324:A:AG | acceptor_gain | 1.0000 |
| 8:142735324:AGGT:A | acceptor_gain | 1.0000 |
| 8:142735324:AGGTG:A | acceptor_gain | 1.0000 |
| 8:142735325:G:GT | acceptor_gain | 1.0000 |
| 8:142735325:GGT:G | acceptor_gain | 1.0000 |
| 8:142735325:GGTG:G | acceptor_gain | 1.0000 |
| 8:142735325:GGTGG:G | acceptor_gain | 1.0000 |
| 8:142727855:GCAGG:G | donor_gain | 0.9900 |
| 8:142727856:CAGGG:C | donor_loss | 0.9900 |
| 8:142727859:GGTGA:G | donor_loss | 0.9900 |
| 8:142727860:G:C | donor_loss | 0.9900 |
| 8:142727860:G:GG | donor_gain | 0.9900 |
| 8:142727861:T:A | donor_loss | 0.9900 |
| 8:142735321:T:TA | acceptor_gain | 0.9900 |
| 8:142735324:AG:A | acceptor_gain | 0.9900 |
| 8:142735325:GG:G | acceptor_gain | 0.9900 |
| 8:142727862:GAGCG:G | donor_loss | 0.9800 |
| 8:142734386:G:GT | donor_gain | 0.9800 |
| 8:142734324:GC:G | donor_gain | 0.9000 |
| 8:142728654:A:T | donor_gain | 0.8900 |
| 8:142734357:G:T | donor_gain | 0.8800 |
| 8:142727860:G:T | donor_gain | 0.8600 |
| 8:142727863:AGCGG:A | donor_loss | 0.8600 |
| 8:142727857:AGG:A | donor_gain | 0.8500 |
| 8:142727858:GGG:G | donor_gain | 0.8500 |
| 8:142729102:C:G | donor_gain | 0.8500 |
AlphaMissense
1303 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:142727756:T:C | F137S | 0.988 |
| 8:142727543:A:T | N66I | 0.984 |
| 8:142735383:A:C | S191R | 0.979 |
| 8:142735385:C:A | S191R | 0.979 |
| 8:142735385:C:G | S191R | 0.979 |
| 8:142727695:T:C | F117L | 0.977 |
| 8:142727697:C:A | F117L | 0.977 |
| 8:142727697:C:G | F117L | 0.977 |
| 8:142727755:T:C | F137L | 0.977 |
| 8:142727757:T:A | F137L | 0.977 |
| 8:142727757:T:G | F137L | 0.977 |
| 8:142727544:C:A | N66K | 0.976 |
| 8:142727544:C:G | N66K | 0.976 |
| 8:142727724:G:C | W126C | 0.976 |
| 8:142727724:G:T | W126C | 0.976 |
| 8:142735362:T:A | W184R | 0.976 |
| 8:142735362:T:C | W184R | 0.976 |
| 8:142727722:T:A | W126R | 0.975 |
| 8:142727722:T:C | W126R | 0.975 |
| 8:142727542:A:T | N66Y | 0.967 |
| 8:142735364:G:C | W184C | 0.967 |
| 8:142735364:G:T | W184C | 0.967 |
| 8:142727547:C:A | N67K | 0.963 |
| 8:142727547:C:G | N67K | 0.963 |
| 8:142727776:T:C | F144L | 0.960 |
| 8:142727778:C:A | F144L | 0.960 |
| 8:142727778:C:G | F144L | 0.960 |
| 8:142727560:C:A | R72S | 0.959 |
| 8:142727519:A:T | D58V | 0.958 |
| 8:142727726:A:T | D127V | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000052565 (8:142735498 A>T), RS1000972215 (8:142726722 C>A,T), RS1001456886 (8:142734490 G>A), RS1001690054 (8:142728264 T>A), RS1001886653 (8:142734863 G>A,T), RS1002180336 (8:142734548 C>A,T), RS1002246538 (8:142727189 C>A,G,T), RS1002637905 (8:142734205 C>T), RS1002961370 (8:142729229 T>G), RS1003160011 (8:142733428 T>C), RS1003188701 (8:142735565 C>T), RS1003593859 (8:142735782 G>A), RS1003705318 (8:142728007 C>A,G,T), RS1004379049 (8:142732573 T>C), RS1004569023 (8:142734458 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066289 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.21 | Kd | 62.14 | nM | CHEMBL5653589 |
| 7.21 | ED50 | 62.14 | nM | CHEMBL5653589 |
| 5.77 | Kd | 1696 | nM | CHEMBL3752910 |
| 5.77 | ED50 | 1696 | nM | CHEMBL3752910 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149581: Binding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0621 | uM |
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149581: Binding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assay | kd | 1.6959 | uM |
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Valproic Acid | affects cotreatment, increases expression, affects expression, increases methylation | 3 |
| bisphenol A | affects expression, increases expression | 2 |
| Copper | affects binding, increases expression, decreases expression | 2 |
| Estradiol | affects cotreatment, decreases expression, affects binding, increases reaction | 2 |
| Tobacco Smoke Pollution | affects expression, decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| bisphenol F | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| abrine | decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Bortezomib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Coumestrol | increases expression, affects cotreatment | 1 |
| Demecolcine | decreases expression | 1 |
| Disulfiram | affects binding, increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652623 | Binding | Binding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.